August 11, 2017 - By Peter Erickson
Analysts expect CounterPath Corp (TSE:PATH) to report $-0.09 EPS on September, 13.They anticipate $0.01 EPS change or 10.00% from last quarter’s $-0.1 EPS. After having $-0.30 EPS previously, CounterPath Corp’s analysts see -70.00% EPS growth. The stock decreased 3.79% or $0.14 on August 10, reaching $3.55. About 910 shares traded or 26.21% up from the average. CounterPath Corp (TSE:PATH) has 0.00% since August 11, 2016 and is . It has underperformed by 16.70% the S&P500.
Alkeon Capital Management Llc increased Northrop Grumman Corp (NOC) stake by 538.19% reported in 2016Q4 SEC filing. Alkeon Capital Management Llc acquired 269,095 shares as Northrop Grumman Corp (NOC)’s stock rose 2.59%. The Alkeon Capital Management Llc holds 319,095 shares with $74.22M value, up from 50,000 last quarter. Northrop Grumman Corp now has $47.10B valuation. The stock decreased 0.93% or $2.55 during the last trading session, reaching $270.55. About shares traded. Northrop Grumman Corporation (NYSE:NOC) has risen 18.39% since August 11, 2016 and is uptrending. It has outperformed by 1.69% the S&P500.
CounterPath Corporation designs, develops and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services, including voice, video, messaging and collaboration functionality, over their Internet Protocol (IP) networks. The company has market cap of $18.25 million. The Company’s solutions range from software products to cloud services. It currently has negative earnings. The Company’s software products include applications for smartphones, tablets and desktop computers, a Software Development Kit (SDK) for software developers seeking to add voice, video and messaging capabilities to their existing applications, and server software solutions for configuring, managing and supporting softphones and for deploying messaging and collaboration services.
Alkeon Capital Management Llc decreased Dollar Tree Inc (NASDAQ:DLTR) stake by 265,005 shares to 2.41M valued at $186.16M in 2016Q4. It also reduced Synopsys Inc (NASDAQ:SNPS) stake by 936,893 shares and now owns 2.43 million shares. Alexion Pharmaceuticals Inc (NASDAQ:ALXN) was reduced too.
Among 14 analysts covering Northrop Grumman (NYSE:NOC), 8 have Buy rating, 0 Sell and 6 Hold. Therefore 57% are positive. Northrop Grumman had 35 analyst reports since July 30, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Hold” rating and $27500 target in Monday, July 17 report. The firm has “Overweight” rating by Barclays Capital given on Thursday, November 10. As per Thursday, August 25, the company rating was downgraded by JP Morgan. RBC Capital Markets initiated the shares of NOC in report on Thursday, January 12 with “Outperform” rating. The stock of Northrop Grumman Corporation (NYSE:NOC) earned “Outperform” rating by RBC Capital Markets on Thursday, July 30. The rating was upgraded by Vertical Research to “Buy” on Thursday, May 11. Drexel Hamilton upgraded the shares of NOC in report on Wednesday, October 28 to “Buy” rating. The stock of Northrop Grumman Corporation (NYSE:NOC) earned “Buy” rating by Argus Research on Friday, August 4. RBC Capital Markets maintained the stock with “Outperform” rating in Thursday, October 29 report. Argus Research maintained Northrop Grumman Corporation (NYSE:NOC) on Thursday, August 6 with “Buy” rating.
Since February 21, 2017, it had 0 insider purchases, and 19 sales for $35.80 million activity. 240 shares were sold by Jones Christopher T, worth $59,688 on Wednesday, March 1. $1.00 million worth of Northrop Grumman Corporation (NYSE:NOC) was sold by ASHWORTH SID. $239,447 worth of Northrop Grumman Corporation (NYSE:NOC) shares were sold by Caylor Mark A. $7.44M worth of Northrop Grumman Corporation (NYSE:NOC) was sold by VICE THOMAS E on Wednesday, May 10. Peppard Denise M. sold $255,184 worth of stock. Shares for $79,654 were sold by Hardesty Michael A. Antkowiak Patrick M. sold $50,117 worth of Northrop Grumman Corporation (NYSE:NOC) on Thursday, February 23.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.